Should patients stop taking aspirin for primary prevention?

Cleve Clin J Med. 2015 Feb;82(2):91-6. doi: 10.3949/ccjm.82a.14114.

Authors

Jeremiah P Depta¹, Deepak L Bhatt^{2

3}

Affiliations

¹ Brigham and Women's Hospital Heart and Vascular Center; Harvard Medical School, Boston, MA, USA.
² Executive Director of Interventional Cardiovascular Programs, Brigham and Women's Hospital Heart and Vascular Center.
³ Professor of Medicine, Harvard Medical School, Boston, MA, USA. E-mail: dlbhattmd@post.harvard.edu.

PMID: 25897597
DOI: 10.3949/ccjm.82a.14114

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Aspirin / adverse effects*
Aspirin / therapeutic use*
Cardiovascular Diseases / prevention & control*
Decision Making*
Gastrointestinal Hemorrhage / chemically induced*
Humans
Platelet Aggregation Inhibitors / adverse effects
Platelet Aggregation Inhibitors / therapeutic use
Primary Prevention / methods*
Risk Factors

Substances

Platelet Aggregation Inhibitors
Aspirin